S1PR3 and lung carcinoma: We previously demonstrated that S1P is involved in the exacerbation of the TLR9-induced inflammatory pathway associated to lung cancer [15,25], as well as in cell proliferation through a SPHK II/S1PR3 nuclear-dependent intracellular mechanism [26].